You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and Neck Squamous Cell Carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Following Salvage Surgery for RESidual or reCurrent sqUamous

Not yet recruiting
  • Head and Neck Cancer
  • Molecular Analyses
  • (no location specified)
Mar 28, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tianjin, China
  • +1 more
May 16, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 17, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • fMRI
  • Oral Pimonidazole
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center
Oct 9, 2023

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins University
Aug 2, 2023

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Cancer
  • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun yat-sun memorial hospital
Jul 10, 2023

Oligometastatic Squamous Cell Carcinoma of the Head and Neck Trial (Pembrolizumab, stereotattic ablation radiotherapy (SABR))

Not yet recruiting
  • Oligometastatic Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Apr 14, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)

Recruiting
  • Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Intensity-modulated radiotherapy
  • Magnetic Resonance Guidance
  • Tampa, Florida
    Moffitt Cancer Center
Nov 13, 2023

Head and Neck Squamous Cell Carcinoma, Magnetic Resonance Imaging, Neoadjuvant Therapy Trial in Guangzhou

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Jul 27, 2023

    Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial (ALE.C04, Pembrolizumab)

    Not yet recruiting
    • Head and Neck Cancer
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Sep 19, 2023

    Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Oropharynx
    • Radiation Therapy
    • Miami, Florida
    • +3 more
    Jul 22, 2023

    Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Basal Cell Carcinoma of Skin
    • microscopy confocal (Histolog Scanner)
    • Vandœuvre-lès-Nancy, France
      Gilles Dolivet
    Jul 7, 2023

    Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinomas
    • Tislelizumab + Dasatinib + Quercetin
    • surgery
    • (no location specified)
    Feb 2, 2023

    HNSCC Trial in Chengdu (Nituozumab)

    Recruiting
    • HNSCC
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Apr 16, 2023

    Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)

    Recruiting
    • Head and Neck Carcinoma
    • Elective nodal de-escalation arm
    • Cairo, Egypt
      National Cancer Institute
    Dec 6, 2022

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Feb 10, 2023